WORLD Peru inks deal with Sinopharm for COVID-19 vaccines

WORLD

Peru inks deal with Sinopharm for COVID-19 vaccines

Xinhua

16:22, January 07, 2021

A signage of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, Sept 5, 2020. (Photo: Agencies)

Peru has signed an agreement with Chinese pharmaceutical firm Sinopharm to acquire its vaccine against COVID-19, with the first 1 million doses to arrive this month, Peruvian President Francisco Sagasti announced Wednesday.

In a nationwide address, Sagasti said Peru's cooperation in Sinopharm phase 3 trials placed the country "in a better position to access vaccines" and to "verify their effectiveness in the national population."

Clinical trials of the Sinopharm vaccine are currently underway at the Cayetano Heredia Peruvian University and the National University of San Marcos.

According to Peru's National Institute of Health, which is overseeing the process, 11,000 volunteers have been vaccinated since the trials began in September.

Peru has registered more than 1 million COVID-19 cases and over 37,000 deaths.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue